Abstract
Patients who received the N‐methyl‐D‐aspartate (NMDA) receptor partial agonist D‐cycloserine as adjunctive treatment to a transcranial magnetic stimulation (TMS) protocol showed greater improvement in depressive symptoms in a 4‐week placebo‐controlled trial. No serious adverse events were reported in the study.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
